levodopa has been researched along with Brain Ischemia in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Kuric, E; Marklund, N; Ruscher, K; Talhada, D; Wieloch, T | 1 |
| Bhakta, BB; Cozens, A; Farrin, AJ; Ford, GA; Hartley, S; Holloway, I; Meads, D; Pearn, J; Ruddock, S; Sackley, CM; Saloniki, EC; Santorelli, G; Walker, MF | 1 |
| Jolkkonen, J; Ortega, FJ | 1 |
| Chen, C; Jiang, P; Liu, L; Wang, W; Zhang, T | 1 |
| Arbouw, ME; Egberts, TC; Guchelaar, HJ; Movig, KL; Neef, C | 1 |
| Inoue, M; Inoue, Y; Kishimoto, T; Kiuchi, K; Kosaka, J; Morikawa, M; Norimoto, K | 1 |
| Gupta, D; Kuruvilla, A | 1 |
| Huang, Z; Jacewicz, M; Pfeiffer, RF | 1 |
| Ianishevskiĭ, SN; Kovalenko, PA; Lobzin, SV; Odinak, MM; Vozniuk, IA | 1 |
| Caccia, C; Calabresi, M; Curatolo, L; Faravelli, L; Fariello, RG; Maestroni, S; Maj, R; Salvati, P | 1 |
| Frackowiak, RS; Gibbs, JM; Jones, T; Lammertsma, AA; Leenders, KL | 1 |
| Le Poncin-Lafitte, M; Lespinasse, P; Martin, P; Rapin, JR | 1 |
| Alonso, RJ; Covington, TR; Mancall, EL | 1 |
| Duché, B; Loiseau, P; Tison, F | 1 |
| Golubev, VL; Shtul'man, DR; Shvareva, IS; Veĭn, AM; Zhuchenko, TD | 1 |
| Barber, A; Bender, HM; Gottschlich, R; Greiner, HE; Harting, J; Mauler, F; Seyfried, CA | 1 |
| Akaike, A; Arai, N; Fujita, K; Furukawa, N; Goshima, Y; Hashimoto, M; Misu, Y; Miyamae, T; Sasaki, Y; Yamamoto, I | 1 |
| Arai, N; Fujita, K; Furukawa, N; Goshima, Y; Misu, Y; Miyamae, T; Ohshima, E; Sasaki, Y; Suzuki, F | 1 |
| Eidelberg, D; Frucht, SJ; Scarmato, N; Scarmeas, N | 1 |
| Abe, T; Takahashi, S; Tohgi, H; Utsugisawa, K | 1 |
| Schnaberth, G | 1 |
5 review(s) available for levodopa and Brain Ischemia
| Article | Year |
|---|---|
Restorative therapies to enhance sensorimotor recovery following cerebral ischemia.
Topics: Animals; Antidepressive Agents; Brain Ischemia; Central Nervous System Stimulants; Cerebral Infarction; Humans; Levodopa; Neurogenesis; Neuronal Plasticity; Physical Therapy Modalities; Recovery of Function | 2013 |
Vascular parkinsonism: what makes it different?
Topics: Antiparkinson Agents; Brain Ischemia; Dementia; Gait Disorders, Neurologic; Humans; Levodopa; Parkinson Disease, Secondary | 2011 |
Safinamide: from molecular targets to a new anti-Parkinson drug.
Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Brain Ischemia; Disease Models, Animal; Gerbillinae; Humans; Kainic Acid; Levodopa; Mice; MPTP Poisoning; Neurons; Rats; Veratridine | 2006 |
Positron emission tomography of the brain: new possibilities for the investigation of human cerebral pathophysiology.
Topics: Aging; Amino Acids; Arterial Occlusive Diseases; Brain; Brain Ischemia; Brain Neoplasms; Carotid Artery Diseases; Cerebral Infarction; Cerebrovascular Disorders; Dementia; Epilepsy; Fluorine; Forecasting; Homeostasis; Humans; Huntington Disease; Isotopes; Levodopa; Mental Disorders; Models, Biological; Neurology; Oxygen Radioisotopes; Parkinson Disease; Radioisotopes; Receptors, Drug; Reference Values; Respiration; Tomography, Emission-Computed | 1984 |
[Vascular hemi-parkinson disease].
Topics: Aged; Aspirin; Benserazide; Brain Ischemia; Drug Therapy, Combination; Female; Functional Laterality; Humans; Intracranial Arteriosclerosis; Levodopa; Magnetic Resonance Imaging; Neostriatum; Parkinson Disease | 1993 |
2 trial(s) available for levodopa and Brain Ischemia
| Article | Year |
|---|---|
Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Carbidopa; Dopamine Agents; Double-Blind Method; Drug Combinations; Female; Humans; Intracranial Hemorrhages; Levodopa; Male; Middle Aged; Mobility Limitation; Occupational Therapy; Physical Therapy Modalities; Prospective Studies; Stroke; Stroke Rehabilitation; Treatment Outcome | 2019 |
[Madopar in the complex therapy of ischemic insult].
Topics: Aged; Aged, 80 and over; Benserazide; Blood Pressure; Brain Ischemia; Cognition; Dopamine Agents; Drug Administration Schedule; Drug Combinations; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Stroke; Treatment Outcome | 2005 |
14 other study(ies) available for levodopa and Brain Ischemia
| Article | Year |
|---|---|
Plasticity-Enhancing Effects of Levodopa Treatment after Stroke.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Down-Regulation; GAP-43 Protein; Infarction, Middle Cerebral Artery; Levodopa; Male; Mice; Neuronal Plasticity; Nogo Proteins; Nogo Receptors; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Rats, Wistar; Stroke; Thrombosis | 2021 |
Levodopa improves learning and memory ability on global cerebral ischemia-reperfusion injured rats in the Morris water maze test.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Levodopa; Male; Maze Learning; Memory; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury | 2017 |
Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Brain Ischemia; Case-Control Studies; Databases, Factual; Dopamine Agonists; Drug Prescriptions; Ergolines; Female; Hospitalization; Humans; Ischemia; Levodopa; Male; Myocardial Ischemia; Netherlands; Parkinson Disease; Practice Patterns, Physicians'; Prevalence; Raynaud Disease; Severity of Illness Index | 2012 |
Parkinsonism with multiple cysts in the bilateral striata.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Antipsychotic Agents; Brain Ischemia; Delirium; Delusions; Diagnosis, Differential; Dibenzothiazepines; Dominance, Cerebral; Drug Therapy, Combination; Encephalomalacia; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neostriatum; Neurologic Examination; Organophosphate Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced; Quetiapine Fumarate; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Anticardiolipin antibody in vascular parkinsonism.
Topics: Aged; Antibodies, Anticardiolipin; Antiparkinson Agents; Brain; Brain Ischemia; Cerebrovascular Circulation; Cognition Disorders; Female; Gait; Humans; Levodopa; Lower Extremity; Male; Neuropsychological Tests; Parkinson Disease, Secondary; Posture; Risk Factors | 2002 |
[Cerebral ischemia after ligature of both carotid arteries in rats: effect of ginkgo biloba extracts (author's transl)].
Topics: Animals; Brain; Brain Ischemia; Carotid Arteries; Cerebrovascular Circulation; Dopamine; Levodopa; Ligation; Norepinephrine; Plant Extracts; Rats | 1982 |
Therapy of neurologic disorders in the elderly.
Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl | 1984 |
[Vascular parkinsonism].
Topics: Antiparkinson Agents; Brain Ischemia; Carbidopa; Drug Combinations; Electroencephalography; Female; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease, Secondary; Ultrasonography, Doppler, Transcranial | 1998 |
Effects of GR-89696 and the novel peripherally selective OP2 agonists, EMD-61569 and EMD-61747, against focal cerebral ischemia in the rat.
Topics: Animals; Binding, Competitive; Brain Edema; Brain Ischemia; Cerebral Arteries; Levodopa; Ligation; Male; Neuroprotective Agents; Piperazines; Pyrroles; Pyrrolidines; Rabbits; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Opioid, kappa | 1999 |
[A DOPA antagonist, DOPA cyclohexyl ester inhibits transient brain ischemia-induced release of glutamate and delayed neuronal cell death in striatal and hippocampal region of in vivo rats].
Topics: Animals; Brain Ischemia; Cell Death; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Glutamates; Hippocampus; Levodopa; Male; Microdialysis; Rats; Rats, Wistar | 1999 |
DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats.
Topics: Animals; Brain Ischemia; Cell Death; Dihydroxyphenylalanine; Glutamic Acid; Hippocampus; Levodopa; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Organ Culture Techniques; Rats; Rats, Wistar; Reperfusion Injury | 2001 |
Oculogyric-like crises in a 92-year-old woman with vascular Parkinsonism.
Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Brain; Brain Ischemia; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Ocular Motility Disorders; Parkinson Disease, Secondary; Treatment Outcome | 2001 |
Symptomatic characteristics of parkinsonism and the width of substantia nigra pars compacta on MRI according to ischemic changes in the putamen and cerebral white matter: implications for the diagnosis of vascular parkinsonism.
Topics: Aged; Antiparkinson Agents; Brain Infarction; Brain Ischemia; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Motor Activity; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Substantia Nigra | 2001 |
["Parkinson plus." Multisystem involvement in Parkinson disease].
Topics: Brain Ischemia; Dopamine; Humans; Levodopa; Muscle Rigidity; Neurocognitive Disorders; Parkinson Disease | 1986 |